We are committed to finding a cure for WM.

Did you know?

 

Welcome to the Waldenstrom’s Macroglobulinemia Foundation of Canada (WMFC)

If you have been diagnosed with Waldenstrom’s Macroglobulinemia (WM) or care for someone who has, welcome to the WMFC family of WM patients, caregivers, friends and relatives. We are a community providing support, research and information on WM.

Sign up for our newsletter below to receive updated information.

 

Information for the newly diagnosed

“Choose Hope” – September is Blood Cancer Awareness Month….

Waldenstrom’s Macroglobulinemia is one of 137 types of blood cancer. WM is a rare sub-type of non-Hodgkin’s Lymphoma characterized by a proliferation of lymphoplasmacytic cells.   More Canadians than everRead More

Murray Shaw: Cancer is My Hobby

As someone living with an “indolent” cancer (slow to develop, treatable, but so-far incurable) for the last dozen years, I have decided that the best way for me to thinkRead More

BGB-3111: Small Molecule BTK Inhibitor to Treat B-Cell Malignancies

BGB-3111 is a potent and highly selective small molecule BTK inhibitor (Bruton’s Tyrosine Kinase), which we are developing as a monotherapy and in combination with other therapies for the treatmentRead More

Dr. Trotman on BGB-3111 in Patients With Waldenstrom’s Macroglobulinemia

Judith Trotman, MD, clinical associate professor, medicine, Concord Clinical School, The University of Sydney, discusses results of a trial investigating BGB-3111 in patients with Waldenstrom’s macroglobulinemia (WM). BGB-3111 is aRead More

Subscribe to our newsletter